Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
This study has been terminated.
( Lack of efficacy )
Study NCT00312286   Information provided by Takeda

First Received on April 6, 2006.   Last Updated on January 31, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Papillomavirus Infections
More general conditions related to this trial
DNA Virus Infections
Tumor Virus Infections
Virus Diseases
Interventions listed in this trial
851B
Sponsors listed in this trial
Takeda


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services